Phenotypic characterization of immortalized normal and primary tumor- derived human prostate epithelial cell cultures

Prostate

Volumn 44, Issue 2, 2000, Pages 164-171

  Schwab, Tracy S ^a   Stewart, Tylitha ^a   Lehr, Jeff ^a   Pienta, Kenneth J ^a,b   Rhim, Johng S ^c   Macoska, Jill A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cell lines; Primary tumors; Prostate; Transformation; Tumorigenesis

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL IMMORTALIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; CELL DIVISION; CELL LINE, TRANSFORMED; CULTURE MEDIA, SERUM-FREE; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MALE; METRIBOLONE; MICE; MICE, NUDE; PAPILLOMAVIRIDAE; PHENOTYPE; PROSTATE; PROSTATIC NEOPLASMS; SIMIAN VIRUS 40; TESTOSTERONE CONGENERS; TETRAZOLIUM SALTS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034235769     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000701)44:2<164::AID-PROS9>3.0.CO;2-4     Document Type: Article

References (31)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000;50:7-33.
2. Bright K, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM, Topalian SL. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997;57:995-1002.
3. Kaign ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). J Urol 1979;17:16-23.
4. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 1978;21:274-281.
5. Horoszewicz AS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-1818.
6. Hzumi T, Yazaki T, Kanoh S, Kondo I, Koiso K. Establishment of a new prostatic carcinoma cell line (TSU-PR1). J Urol 1987; 137:1304-1306.
7. Macoska JA, Beheshti B, Rhim JS, Hukku B, Lehr J, Pienta KJ, Squire JA. Genetic characterization of immortalized prostate epithelial cell cultures: evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumor-derived cells. Cancer Genet Cytogenet 2000; in press.
8. Huibregtse JM, Beaudenon SL. Mechanism of HPV E6 proteins in cellular transformation. Semin Cancer Biol 1996,7:317-326.
9. Jones DL, Thompson DA, Munger K. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 1997;239:97-107.
10. Steeenbergen RDM, Walboomers JMM, Meijer CJLM, van der Raaij-Helmer EMH, Parker JN, Chow LT, Broker TR, Snijders PJF. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 1996;13:1249-1257.
11. Coursen JD, Bennett WP, Gollahon L, Shay JW, Harris CC. Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes. Exp Cell Res 1997;235:245-253.
12. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999;21:115-118.
13. Brugge JS, Butel JS. Role of the simian virus 40 gene A function in maintenance of transformation. J Virol 1975;15:619-635.
14. Martin RG, Chou JY. Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J Virol 1975;15:599-612.
15. Tegtmeyer P. Function of simian virus 40 gene A in transforming infection. J Virol 1975;15:613-618.
16. Jha KK, Banga S, Palejwala V, Ozer HL. SV40-mediated immortalization. Exp Cell Res 1998;245:1-7.
17. Ozer HL, Banga SS, Dasbupta T, Houghton JM, Hubbard K, Jha KK, Kim S-H, Lehahan M, Pang Z, Pardinas JR, Patsalis P. SV40-mediated immortalization of human fibroblasts. Exp Gerontol 1996;31303-310.
18. Gilles C, Piette J, Rombouts S, Laurent C, Foidart J-M. Immortalization of human cervical keratinocytes by human papilloma-virus type 33. Int J Cancer 1993;53:872-879.
19. Oda D, Bigler L, Mao E-J, Disteche CM. Chromosomal abnormalities in HPV-16 immortalized oral epithelial cells. Carcinogenesis 1996;17:2003-2008.
20. Hoffschir F, Ricoul M, Dutrillaux B. SV40-transformed human fibroblasts exhibit a characteristic chromosomal pattern. Cytogenet Cell Genet 1988;49:264-268.
21. Ray FA, Peabody DS, Cooper J, Scott-Cram L, Kraemer PM. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 1990;42:13-31.
22. Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM. Lipofection mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 1994;54:5579-5583.
23. Beheshti B, Karaskova J, Park OC, Squire J, Beatty BG. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential Giemsa-banding and spectral karyotyping. Mol Diagn 2000; 5:23-32.
24. Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ. Evidence for three tumor supressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 1995;55:5390-5395.
25. Vocke C, Pozzatti RO, Bostwick DG, Florence CD, Jennings SB, Strup SE, Duray PH, Liotta LA, Emmert-Buck MR, Linehan WM. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res 1996;56:2411-2416.
26. Prasad MA, Wojno KJ, Macoska JA. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site. Genes Chromosomes Cancer 1998;23:255-262.
27. Macoska J, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE. Fluorescence in situ hybridization (FISH) analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994;54:3824-3830.
28. Van Den Berg C, Guan X-Y, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1995;1: 11-18.
29. 0) prostate carcinoma. Clin Cancer Res 1996;2:137-145.
30. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal aneusomies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997;57:524-531.
31. Gustafson CE, Wilson PJ, Lukeis R, Baker E, Woollatt E, Annab L, Hawke L, Barrett JC, Chenevix-Trench G. Functional evidence for a colorectal cancer tumor supperssor gene at chromosome 8p22-23 by monochrome transfer. Cancer Res 1996;56: 5238-5245.